by Eric Christianson | Jan 21, 2024 | Respiratory Medication and Disease State Clinical Pearls
There are so many inhalers on the market for asthma and COPD. LABA, LAMA, and ICS products are getting so hard to keep track of! Honestly, it gets a little overwhelming at times to remember them all by brand name and what category and classification they fall into. My...
by Eric Christianson | Dec 6, 2023 | Respiratory Medication and Disease State Clinical Pearls
Patients who live with asthma or COPD often require the use of inhaler(s) to help manage symptoms of their disease. As healthcare professionals we must ensure that the medications these patients are receiving actually work. In this article, we provide a table on...
by Eric Christianson | Mar 5, 2023 | Clinical Guideline Updates For Pharmacists, Respiratory Medication and Disease State Clinical Pearls
The 2023 GOLD Guidelines were released a little while ago and I don’t think there is anything earth-shattering in medication selection. The biggest thing associated with these guidelines compared to previous editions is the fact that it encourages a little more...
by Eric Christianson | Aug 21, 2022 | Respiratory Case Studies
KE is a 66-year-old male with a history of cigarette smoking (still currently smoking), COPD, atrial fibrillation, hypertension, osteoarthritis, and GERD. In this COPD case review, he reports that he is having a more difficult time breathing, in particular, he notes...
by Eric Christianson | Apr 6, 2022 | Educational Case Studies For Pharmacists, Respiratory Case Studies
In this COPD case study, we outline how to use the GOLD guidelines to guide medication therapy. Here’s the case! KE is a 71-year-old male who has a history of cigarette smoking for 50+ years, COPD, cardiovascular disease, hypertension, peripheral arterial...
